(NASDAQ: HURA) Tuhura Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 45.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.81%.
Tuhura Biosciences's earnings in 2025 is -$33,663,123.On average, 6 Wall Street analysts forecast HURA's earnings for 2025 to be -$32,938,445, with the lowest HURA earnings forecast at -$33,153,729, and the highest HURA earnings forecast at -$32,292,594. On average, 6 Wall Street analysts forecast HURA's earnings for 2026 to be -$28,755,786, with the lowest HURA earnings forecast at -$32,651,400, and the highest HURA earnings forecast at -$24,219,445.
In 2027, HURA is forecast to generate -$34,506,943 in earnings, with the lowest earnings forecast at -$37,172,363 and the highest earnings forecast at -$31,216,174.